Financials Curasight A/S

Equities

CURAS

DK0061295797

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-07-04 pm EDT 5-day change 1st Jan Change
12.05 DKK -4.74% Intraday chart for Curasight A/S -3.60% -32.11%

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 461.6 555 202.5 353.1
Enterprise Value (EV) 1 425.3 481.5 152.6 333
P/E ratio -84.2 x -73.4 x -11.1 x -13.4 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA -520 x -122 x -9.43 x -10.3 x
EV / FCF -63,061,182 x -86,389,780 x -8,763,843 x -14,480,795 x
FCF Yield -0% -0% -0% -0%
Price to Book 7.81 x 5.6 x 3.52 x 11.3 x
Nbr of stocks (in thousands) 17,126 19,894 19,894 19,894
Reference price 2 26.95 27.90 10.18 17.75
Announcement Date 2/24/21 2/24/22 2/22/24 2/22/24
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales - - - - -
EBITDA 1 -1.63 -0.8186 -3.949 -16.18 -32.23
EBIT 1 -1.703 -0.8922 -4.96 -18.96 -33.21
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -1.712 -5.774 -8.753 -19.49 -33.22
Net income 1 -1.335 -5.552 -7.579 -18.35 -26.17
Net margin - - - - -
EPS 2 -0.1000 -0.3200 -0.3800 -0.9200 -1.320
Free Cash Flow - -6.744 -5.573 -17.41 -23
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 2/24/21 2/24/21 2/24/22 2/22/24 2/22/24
1DKK in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 1.2 36.3 73.6 49.9 20.1
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -6.74 -5.57 -17.4 -23
ROE (net income / shareholders' equity) - -14.4% -9.58% -23.4% -58.8%
ROA (Net income/ Total Assets) - -1.3% -3.74% -14.6% -42.2%
Assets 1 - 426.4 202.6 125.6 62.03
Book Value Per Share 2 1.350 3.450 4.980 2.890 1.580
Cash Flow per Share 2 0.0900 2.120 3.700 2.510 1.010
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 2/24/21 2/24/21 2/24/22 2/22/24 2/22/24
1DKK in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. CURAS Stock
  4. Financials Curasight A/S